Effects of VIVIFRAIL Program on Functional Capacity and Geriatric Syndromes in the Elderly.
VIVIAL
Effects of the VIVIFRAIL Multicomponent Physical Exercise Program on Functional Capacity and Geriatric Syndromes in Frail and Pre-frail Older Adults Over 70 Years in Primary Care in Almeria: A Quasi-Experimental Study.
1 other identifier
interventional
86
1 country
1
Brief Summary
The aim of this quasi-experimental, pretest-posttest study is to evaluate the effectiveness of the Vivifrail multicomponent physical exercise program in improving the functional capacity of pre-frail and frail older adults (aged 70 and older) attending the Virgen del Mar Health Center in Almería. The main questions it aims to answer are:
- Does functional capacity, as measured by the Short Physical Performance Battery (SPPB), significantly improve after participating in the Vivifrail program?
- What is the effect of the Vivifrail program on various geriatric syndromes and associated health conditions (e.g., fall risk, sarcopenia, chronic pain, mild cognitive impairment, depression), and what patient profile is most likely to benefit from the intervention?
- As a single-arm interventional study, there is no parallel comparison group. Researchers will compare each participant's outcomes against their own baseline at three time points (baseline, week 6, and week 12) to assess for significant improvements following the intervention. Participants will:
- Complete a 12-week home-based, multicomponent physical exercise program (five sessions per week including strength, balance, flexibility, and aerobic endurance training), tailored to their baseline functional level.
- Attend three in-person visits at the health center (baseline, a 6-week follow-up, and a final visit at 12 weeks) for the research staff to assess their clinical, functional, and sociodemographic variables.
- Complete an Activity Diary to record their home-based sessions and perceived rate of exertion in order to monitor adherence.
- Receive biweekly follow-up phone calls from the research team to reinforce motivation, track adherence, and monitor for any potential adverse events (e.g., falls, pain).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedStudy Start
First participant enrolled
March 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2026
CompletedFebruary 27, 2026
February 1, 2026
3 months
February 22, 2026
February 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Functional Capacity measured by the Short Physical Performance Battery (SPPB)
The SPPB assesses physical performance and functional capacity through three sequential subtests: static balance (side-by-side, semi-tandem, and tandem stands for 10 seconds each), gait speed (time to walk 4 meters at a normal pace), and lower body strength (time to rise from a chair and sit down 5 consecutive times). The total SPPB score is calculated by summing the scores of the three subtests, yielding a final continuous score that ranges from 0 to 12. Clinical thresholds: A total score of \< 10 points indicates a high probability of frailty and an elevated risk of disability and falls. According to the Vivifrail classification, the scores categorize the patient's functional level as Disability (0-3 points), Frailty (4-6 points), Pre-frailty (7-9 points), or Robustness (10-12 points). A change of 1 point is considered clinically meaningful.
Baseline, Week 6, and Week 12
Secondary Outcomes (12)
Body Mass Index (BMI)
Baseline, Week 6, and Week 12
Chronic Pain Intensity measured by the Visual Analogue Scale (VAS)
Baseline, Week 6, and Week 12
Appetite Perception measured by the Visual Analogue Scale (VAS)
Baseline, Week 6, and Week 12
Proportion of Participants with High Fall Risk according to Vivifrail Criteria
Baseline, Week 6, and Week 12
Functional Mobility measured by the Timed Up and Go (TUG) Test
Baseline, Week 6, and Week 12
- +7 more secondary outcomes
Study Arms (1)
Vivifrail Exercise Program
EXPERIMENTALAll participants in this single-arm study are assigned to the experimental group. Following a baseline clinical and functional assessment, participants are categorized into specific functional profiles based on their frailty status and fall risk. Participants are monitored over a 12-week period, which includes three in-person visits at the health center (baseline, week 6, and week 12) for functional reassessment, alongside biweekly telephone follow-ups by the research team to monitor adherence, safety, and potential adverse events.
Interventions
The Vivifrail multicomponent physical exercise program is a structured, 12-week home-based regimen. The standardized protocol requires 5 sessions per week: 3 non-consecutive days of 45-60 minute multicomponent training (focusing on upper and lower body strength using household items like water bottles or elastic bands, static/dynamic balance, and flexibility) and 2 days of 20-40 minute aerobic endurance training (brisk walking). Exercise intensity is prescribed at a moderate rate of perceived exertion (Borg scale 4-6). A systematic progression in exercise load and duration is implemented starting at week 7, strictly adhering to the guidelines of the participant's assigned passport.
Eligibility Criteria
You may qualify if:
- Participants aged 70 years or older.
- Classified as pre-frail or frail according to the FRAIL scale (score ≥ 1).
- Barthel Index score ≥ 60 points.
- Ability to communicate effectively.
- Ability to ambulate, with or without assistive devices.
You may not qualify if:
- Recent acute myocardial infarction or unstable angina.
- Uncontrolled atrial or ventricular arrhythmias.
- Dissecting aortic aneurysm.
- Severe aortic stenosis.
- Acute endocarditis or pericarditis.
- Uncontrolled arterial hypertension.
- Acute thromboembolic disease.
- Severe acute heart failure.
- Severe acute respiratory failure.
- Uncontrolled orthostatic hypotension.
- Diabetes mellitus with acute decompensation or uncontrolled hypoglycemia.
- Recent bone fracture within the last month.
- Institutionalization (e.g., nursing home residents).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Primary Care Center Virgen del Mar (Centro de Salud Virgen del Mar)
Almería, ALMERÍA, 04009, Spain
Related Publications (2)
Casas-Herrero A, Saez de Asteasu ML, Anton-Rodrigo I, Sanchez-Sanchez JL, Montero-Odasso M, Marin-Epelde I, Ramon-Espinoza F, Zambom-Ferraresi F, Petidier-Torregrosa R, Elexpuru-Estomba J, Alvarez-Bustos A, Galbete A, Martinez-Velilla N, Izquierdo M. Effects of Vivifrail multicomponent intervention on functional capacity: a multicentre, randomized controlled trial. J Cachexia Sarcopenia Muscle. 2022 Apr;13(2):884-893. doi: 10.1002/jcsm.12925. Epub 2022 Feb 11.
PMID: 35150086BACKGROUNDGuralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994 Mar;49(2):M85-94. doi: 10.1093/geronj/49.2.m85.
PMID: 8126356BACKGROUND
Related Links
- Ministerio de Sanidad. Actualización del documento de consenso sobre prevención de la fragilidad en la persona mayor (2022).
- Integrated care for older people: guidelines on community-level interventions to manage declines in intrinsic capacity.
- Izquierdo M. Prescripción de ejercicio físico. El programa Vivifrail como modelo. Nutr Hosp 2019;36(N.o Extra. 2):50-56.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Family Medicine Resident
Study Record Dates
First Submitted
February 22, 2026
First Posted
February 27, 2026
Study Start
March 16, 2026
Primary Completion
June 15, 2026
Study Completion
June 15, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Due to European General Data Protection Regulation (GDPR) and national data privacy laws regarding sensitive health data in frail elderly populations, individual participant data cannot be publicly shared or transferred to third parties. The informed consent approved by the Ethics Committee restricts data access exclusively to the core research team. However, aggregate data and detailed methodology will be fully available in the published article.